Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY:CVS)

70.97 +0.80 (+1.14%)
Official Closing Price Updated: 7:00 PM EDT, Aug 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
60 61 Next >
These S&P500 stocks are moving in today's session
Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday?
A hotter-than-expected inflation report initially rattled markets on Wednesday morning, but investors found confidence to buy the dip, helping major indexes recover most losses by midday trading in New... 
Via Benzinga
Topics Economy
CVS Health (CVS) Q4 2024 Earnings Call Transcript
CVS earnings call for the period ending December 31, 2024. 
Via The Motley Fool
Topics Earnings
Market Whales and Their Recent Bets on CVS Options
 
Via Benzinga
Why CVS Health Stock Popped Today
Via The Motley Fool
Earnings Scheduled For February 12, 2025
 
Via Benzinga
What's a Fair Price for CVS Stock?
Via The Motley Fool
Crude Oil Down Over 2%; Upstart Shares Jump Following Earnings
 
Via Benzinga
CVS Beats EPS Estimates, Losses Loom
CVS Health reported mixed fourth-quarter earnings, beating estimates but showing challenges in key areas. 
Via The Motley Fool
Gilead Sciences, Upstart, Mercury General, Confluent And Other Big Stocks Moving Higher On Wednesday
 
Via Benzinga
Discover the top S&P500 movers in Wednesday's pre-market session.
Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top S&P500 gainers and losers in today's pre-market session. 
Via Chartmill
Peering Into CVS Health's Recent Short Interest
 
Via Benzinga
Is CVS Health's Dividend Safe?
Via The Motley Fool
This House of Representative Just Sold Up To $50K In CVS Health Stock
 
Via Benzinga
CVS Health Q4 Earnings: Revenue And EPS Beat, Same-store Prescription Volume Up 5.9%, Upbeat FY25 Outlook And More
CVS Health posted Q4 sales of $97.71B, with a 23.3% rise in Health Care Benefits revenue. Fiscal 2025 adjusted EPS guidance set at $5.75-$6.00. 
Via Benzinga
CVS Health Surges Premarket As Q4 Earnings Blow Past Estimates, Retail Buzz Builds
The company said it continues to see growth in Pharmacy and Consumer Wellness while working to address challenges in its Health Care Benefits segment. 
Via Stocktwits
CVS Health’s (NYSE:CVS) Q4 Sales Top Estimates, Stock Soars
Diversified healthcare company CVS Health (NYSE:CVS) announced better-than-expected revenue in Q4 CY2024, with sales up 4.2% year on year to $97.71 billion. Its non-GAAP profit of $1.19 per share was... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
US Stocks Set For A Cautious Start Ahead Of Inflation Data: Expert Says 'Strong Bull Markets Tend To Roar Back To Life After Corrections'
U.S. stock futures fell on Wednesday after a mixed close on Tuesday as Federal Reserve Chairman Jerome Powell Congress testimony. 
Via Benzinga
Topics Economy
Should You Buy CVS Health Stock Before Feb. 12?
Via The Motley Fool
Dow Gains Over 100 Points Following Powell Comments: Fear & Greed Index Remains In 'Neutral' Zone
 
Via Benzinga
Topics Stocks
CVS Health, Kraft Heinz And 3 Stocks To Watch Heading Into Wednesday
 
Via Benzinga
CVS Health Stock Is Relatively Cheap, Analyst Highlights Cost Trend Pressure Ahead Of Q4 Earnings
CVS Health reports Q4 earnings on Feb. 12, with analysts watching cost trends, Medicare Advantage enrollment, and medical loss ratio impacts. 
Via Benzinga
CVS Stock Approaches Q4 Earnings With Resistance In Sight
CVS Health (CVS) reports Q4 earnings on Wed. Stock is down 29.78% in past yr, up 22.72% YTD. Bullish trend but mixed signals. Analysts rate it a Buy with avg price tgt $63.67, potential 17.01% upside.... 
Via Benzinga
CVS Health (CVS) Q4 Earnings Report Preview: What To Look For
Diversified healthcare company CVS Health (NYSE:CVS) will be announcing earnings results tomorrow morning. Here’s what investors should know. 
Via StockStory
Billionaire Money Managers Are Piling Into 3 High-Yield Dividend Stocks Amid a Historically Pricey Stock Market
Value-focused billionaire asset managers are trading out pricey stocks for perceived-to-be safe, income-producing, brand-name businesses. 
Via The Motley Fool
Cigna Misses EPS: What It Means for the Health Insurance Industry
Cigna is one of the most efficiently managed health insurance companies evidenced by its foresight to sell its Medicare Advantage business before the fallout. 
Via MarketBeat
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
 
Via Benzinga
Teva Pharma: Why This Generic Drug Giant Is a Smart Buy Now
Teva Pharmaceuticals is the world's largest generic drug maker with over 500 generics in its portfolio, but shares sold off on its recent earnings, buying opp? 
Via MarketBeat
CVS Health Stock Price Is Recovering: Feb 12 Will Be Crucial
CVS Health share price has rebounded by 33% from its lowest point in December. The company will publish its fourth-quarter results on February 12. Technicals point to more CVS Health stock surge in the... 
Via Talk Markets
Topics Stocks / Equities
RFK Jr. And Big Pharma: Health Secretary Hopeful Answers Pointed Questions On Drugs, Insurance, Trump Exec Orders
Kennedy seeks to be Secretary of Health and Human Services — a position that would put him in charge of the health of the American people. 
Via Benzinga
Topics Government
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
60 61 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.